For the first time, two RNA-modifying enzymes, namely PUS7 and WTAP, are identified, as being very likely directly involved in the known differences regarding proliferation and malignancy of the three most relevant RCC subtypes—ccRCCs, pRCCs, and chRCCs. Here, PUS7 is linked to renal cell carcinoma.